Aflac Inc.

Aflac Inc.

AFL

Get informed when a big investor buys or sells

+ Follow
Market Cap$57.22B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Aflac Inc.Aflac Inc.12.42.12%21%3.30.3

Earnings Call Q1 2026

April 30, 2026 - AI Summary

Strong Financial Performance: Aflac Incorporated reported net earnings per diluted share of $1.98 and adjusted earnings per diluted share of $1.75 for Q1 2026, marking a 6.6% year-over-year increase in adjusted earnings. The company's solid execution on its strategy is contributing to long-term shareholder value.
Sales Growth in Japan: Aflac Japan experienced a substantial 25.5% sales increase in Q1, driven by the success of its new medical product Onsen Tallett and the Miraito cancer insurance product. This growth highlights Aflac Japan's effective marketing and sales transformation initiatives implemented in the previous year.
U.S. Business Stability: Aflac's U.S. operations reported a 2.9% year-over-year increase in sales and maintained a strong premium persistency of 79.3%. Despite challenges in the core agent business, group products are performing well, with a 12.4% sales increase observed in key categories.

Exclusive for Stockcircle Pro members

Sign upSign Up
$111.57

Target Price by Analysts

3.2% downsideAflac Target Price DetailsTarget Price
$80.54

Current Fair Value

30.1% downside

Overvalued by 30.1% based on the discounted cash flow analysis.

Share Statistics

Market cap$57.22 Billion
Enterprise Value$59.74 Billion
Dividend Yield$2.44 (2.12%)
Earnings per Share$6.86
Beta0.62
Outstanding Shares513,071,000

Return

Return on Equity20.66%ROE
Return on Assets3.86%
Return on Invested Capital3.13%

Valuation & Multiples

P/E Ratio12.44P/E Ratio
PEG0.36PEG
Price to Sales3.29Price to Sales
Price to Book Ratio2.26Price to Book Ratio
Enterprise Value to Revenue3.3
Enterprise Value to EBIT15.88
Enterprise Value to Net Income12
Total Debt to Enterprise0.13
Debt to Equity0.35Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
April 29, 2026
EPS Estimate
$1.79
Average shareholder expectation
Revenue Estimate
$4.20 B
Average shareholder expectation

Next Earnings Call

Expected Date
August 4, 2026
EPS Estimate
$1.79
Average shareholder expectation
Revenue Estimate
$4.10 B
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.2916▼ 6.53%
Total Calls2,191,677▼ 14.85%
Total Puts639,029▼ 30.43%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %64.53%▼ 1.47%
Total Invested$37.50B▼ 2.68%
Investors Holding1,705▼ 23.00%

ESG Score

No data

About Aflac Inc.

CEO: Daniel Amos

Relevant Senate Committees

Joint Committee on Taxation

Directly impacts corporate tax structures, capital investment credits, and the overall tax burden on financial markets, all of which critically affect Aflac's financial performance and planning.

Finance

Controls tax policy, which directly impacts Aflac's corporate profitability, and influences entitlement spending (like Medicare), which can affect the broader healthcare and economic environment relevant to insurance products.

Banking, Housing, and Urban Affairs

Directly regulates the financial system, including the Fed and SEC, which profoundly impact interest rates, capital markets, and investment strategies crucial for Aflac's portfolio and profitability.